Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation
- PMID: 22147998
- PMCID: PMC3230021
- DOI: 10.3346/jkms.2011.26.12.1606
Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation
Abstract
To date, clinico-physiologic indices have not been compared with quantitative CT imaging indices in determining the risk of chronic obstructive pulmonary disease (COPD) exacerbation. We therefore compared clinico-physiologic and CT imaging indices as risk factors for COPD exacerbation in patients with COPD. We retrospectively analyzed 260 COPD patients from pulmonary clinics at 11 hospitals in Korea from June 2005 to November 2009 and followed-up for at least one year. At the time of enrollment, none of these patients had COPD exacerbations for at least 2 months. All underwent clinico-physiologic and radiological evaluation for risk factors of COPD exacerbation. After 1 yr, 106 of the 260 patients had at least one exacerbation of COPD. Multiple logistic regression analysis showed that old age, high Charlson Index, and low FEV(1) were significant in a clinico-physiologic model, with C-statistics of 0.69, and that increased age and emphysema index were significant in a radiologic model, with C-statistics of 0.64. The difference between the two models was statistically significant (P = 0.04 by bootstrap analysis). Combinations of clinico-physiologic risk factors may be better than those of imaging risk factors in predicting COPD exacerbation.
Keywords: Computed Tomography; Exacerbation; Pulmonary Disease, Chronic Obstructive; Risk Factors.
Similar articles
-
Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.Ann Am Thorac Soc. 2016 Jul;13(7):1067-75. doi: 10.1513/AnnalsATS.201508-493OC. Ann Am Thorac Soc. 2016. PMID: 27070274
-
Impact of mild exacerbation on COPD symptoms in a Japanese cohort.Int J Chron Obstruct Pulmon Dis. 2016 Jun 9;11:1269-78. doi: 10.2147/COPD.S105454. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27354785 Free PMC article.
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
-
Determining prognosis in acute exacerbation of COPD.Int J Chron Obstruct Pulmon Dis. 2017 Jan 31;12:467-475. doi: 10.2147/COPD.S122382. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28203070 Free PMC article.
-
[COPD: Capture an exacerbation with just five questions].MMW Fortschr Med. 2022 May;164(10):61-63. doi: 10.1007/s15006-022-1024-7. MMW Fortschr Med. 2022. PMID: 35585413 Review. German. No abstract available.
Cited by
-
Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.JMIR Med Inform. 2022 Feb 25;10(2):e33043. doi: 10.2196/33043. JMIR Med Inform. 2022. PMID: 35212634 Free PMC article.
-
Study Design and Outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study.Tuberc Respir Dis (Seoul). 2014 Apr;76(4):169-74. doi: 10.4046/trd.2014.76.4.169. Epub 2014 Apr 25. Tuberc Respir Dis (Seoul). 2014. PMID: 24851130 Free PMC article.
-
Comorbidities of chronic obstructive pulmonary disease in Koreans: a population-based study.J Korean Med Sci. 2012 Aug;27(8):901-6. doi: 10.3346/jkms.2012.27.8.901. Epub 2012 Jul 25. J Korean Med Sci. 2012. PMID: 22876057 Free PMC article.
-
Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.J Med Internet Res. 2022 Jan 6;24(1):e28953. doi: 10.2196/28953. J Med Internet Res. 2022. PMID: 34989686 Free PMC article.
-
Clinical and pulmonary functions profiling of patients with chronic obstructive pulmonary disease experiencing frequent acute exacerbations.Lung India. 2018 Jan-Feb;35(1):21-26. doi: 10.4103/lungindia.lungindia_528_16. Lung India. 2018. PMID: 29319029 Free PMC article.
References
-
- Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498–1504. - PubMed
-
- Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriquez-Roisin R, van Weel C, Zielinski J Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555. - PubMed
-
- Singh JM, Palda VA, Stanbrook MB, Chapman KR. Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review. Arch Intern Med. 2002;162:2527–2536. - PubMed
-
- Kanner RE, Anthonisen NR, Connett JE Lung Health Study Research Group. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001;164:358–364. - PubMed